Cognitive decline correlates with low plasma concentrations of copper in patients with mild to moderate Alzheimer’s disease
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Alzheimer's disease (AD) is a devastating brain disorder clinically characterised by progressive loss of characteristic cognitive abilities. Increasing evidence suggests a disturbed copper (Cu) homeostasis to be associated with the pathological processes. In the present study we analysed the plasma Cu levels and cognitive abilities using the Alzheimer's disease Assessment Scale-cognitive subscale (ADAS-cog) in 32 patients with mild to moderate AD. Statistical analysis revealed a negative correlation between plasma Cu levels and cognitive decline (r=-0.49; P<0.01). Patients with low plasma Cu (mean 82 +/- SD 9) had significant higher ADAS-cog values (mean 23 +/- SD 7), than patients with medium plasma Cu (mean 110 +/- SD 7), who exhibited lower ADAS-cog scores (mean 16 +/- SD 4; ANOVA, P<0.0001). Despite the fact that all patients had plasma Cu levels within the physiological range between 65 microg and 165 microg/dL, 87.5% of the patients revealed a significant negative correlation between plasma Cu and ADAS-cog. This finding supports the hypothesis of a mild Cu deficiency in most AD patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Cherny, R. A., Atwood, C. S., Xilinas, M. E., Gray, D. N., Jones, W. D., McLean, C. A., Barnham, K. J., Volitakis, I., Fraser, F. W., Kim, Y.-S., et al. (2001) · Neuron · doi:10.1016/s0896-6273(01)00317-8 · Cited by 1,447 · cited 1×
“uble brain Cu and Zn levels [8].”
The metallobiology of Alzheimer's disease
Bush, A. I. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(03)00067-5 · Cited by 1,315
Ritchie, C. W., Bush, A. I., Mackinnon, A., Macfarlane, S., Mastwyk, M., MacGregor, L., Kiers, L., Cherny, R., Li, Q.-X., Tammer, A., et al. (2003) · Archives of Neurology · doi:10.1001/archneur.60.12.1685 · Cited by 988 · cited 1×
“When AD patients were treated with clioquinol, the placebo group deteriorated faster than the clioquinol group suggesting a beneficial effect upon clioquinol treatment [15].”
The Amyloid Precursor Protein of Alzheimer's Disease in the Reduction of Copper(II) to Copper(I)
Multhaup, G., Schlicksupp, A., Hesse, L., Beher, D., Ruppert, T., Masters, C. L., & Beyreuther, K. (1996) · Science · doi:10.1126/science.271.5254.1406 · Cited by 678
Self-citationAtwood, C. S., Scarpa, R. C., Huang, X., Moir, R. D., Jones, W. D., Fairlie, D. P., Tanzi, R. E., & Bush, A. I. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0751219.x · Cited by 641
Deibel, M. A., Ehmann, W. D., & Markesbery, W. R. (1996) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(96)00203-1 · Cited by 540
Copper levels are increased in the cerebral cortex and liver of APP and APLP2 knockout mice
White, A. R., Reyes, R., Mercer, J. F. B., Camakaris, J., Zheng, H., Bush, A. I., Multhaup, G., Beyreuther, K., Masters, C. L., & Cappai, R. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01861-2 · Cited by 282
Self-citationStructure of the Alzheimer's Disease Amyloid Precursor Protein Copper Binding Domain
Barnham, K. J., McKinstry, W. J., Multhaup, G., Galatis, D., Morton, C. J., Curtain, C. C., Williamson, N. A., White, A. R., Hinds, M. G., Norton, R. S., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300629200 · Cited by 275
Self-citationThe βA4 amyloid precursor protein binding to copper
Hesse, L., Beher, D., Masters, C. L., & Multhaup, G. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00658-x · Cited by 248
Self-citationElevation of serum copper levels in Alzheimer’s disease
Squitti, R., Lupoi, D., Pasqualetti, P., Dal Forno, G., Vernieri, F., Chiovenda, P., Rossi, L., Cortesi, M., Cassetta, E., & Rossini, P. M. (2002) · Neurology · doi:10.1212/wnl.59.8.1153 · Cited by 239
BORCHARDT, T., CAMAKARIS, J., CAPPAI, R., MASTERS, C. L., BEYREUTHER, K., & MULTHAUP, G. (1999) · Biochemical Journal · doi:10.1042/bj3440461 · Cited by 171
Self-citationTurnlund, J. R., Jacob, R. A., Keen, C. L., Strain, J., Kelley, D. S., Domek, J. M., Keyes, W. R., Ensunsa, J. L., Lykkesfeldt, J., & Coulter, J. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/79.6.1037 · Cited by 163
TRACE ELEMENTS AND COGNITIVE IMPAIRMENT: AN ELDERLY COHORT STUDY
SMORGON, C., Mari, E., Atti, A. R., Nora, E. D., Zamboni, P., Calzoni, F., Passaro, A., & Fellin, R. (2004) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2004.04.050 · Cited by 155
Treiber, C., Simons, A., Strauss, M., Hafner, M., Cappai, R., Bayer, T. A., & Multhaup, G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407410200 · Cited by 149
Self-citationIt all sticks together—the APP-related family of proteins and Alzheimer's disease
Bayer, T. A., Cappai, R., Masters, C. L., Beyreuther, K. T., & Multhaup, G. (1999) · Molecular Psychiatry · doi:10.1038/sj.mp.4000552 · Cited by 122
Self-citationCopper, Ceruloplasmin and Superoxide Dismutase in Patients with Alzheimer’s Disease
Snædal, J., Kristinsson, J., Gunnarsdóttir, S. A., Ólafsdóttir, A., Baldvinsson, M., & Jóhannesson, T. (1998) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017067 · Cited by 67
Mechanisms of Biosynthesis of Mammalian Copper/Zinc Superoxide Dismutase
Bartnikas, T. B., & Gitlin, J. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305435200 · Cited by 59
Elevation of serum copper levels discriminates Alzheimer’s disease from vascular dementia
Squitti, R., Pasqualetti, P., Cassetta, E., Forno, G. D., Cesaretti, S., Pedace, F., Finazzi‐Agrò, A., & Rossini, P. M. (2003) · Neurology · doi:10.1212/01.wnl.0000068013.27968.29 · Cited by 51
Copper Perturbation in 2 Monozygotic Twins Discordant for Degree of Cognitive Impairment
Squitti, R., Cassetta, E., Forno, G. D., Lupoi, D., Lippolis, G., Pauri, F., Vernieri, F., Cappa, A., & Rossini, P. M. (2004) · Archives of Neurology · doi:10.1001/archneur.61.5.738 · Cited by 27
Cited by
Brain foods: The effects of nutrients on brain function.
Gómez-Pinilla, F. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2421 · Cited by 1,372
Copper in the brain and Alzheimer’s disease
Hung, Y. H., Bush, A. I., & Cherny, R. A. (2010) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-009-0600-y · Cited by 498
Mitochondria and Reactive Oxygen Species in Aging and Age-Related Diseases
(2018) · International Review of Cell and Molecular Biology · doi:10.1016/bs.ircmb.2018.05.006 · Cited by 455
Dominguez, L. J., Veronese, N., Vernuccio, L., Catanese, G., Inzerillo, F., Salemi, G., & Barbagallo, M. (2021) · Nutrients · doi:10.3390/nu13114080 · Cited by 433
Risks of Copper and Iron Toxicity during Aging in Humans
Brewer, G. J. (2010) · Chemical Research in Toxicology · doi:10.1021/tx900338d · Cited by 395
Metadata
- Authors
- Pajonk, F.-G., Kessler, H., Supprian, T., Hamzei, P., Bach, D., Schweickhardt, J., Herrmann, W., Obeid, R., Simons, A., Falkai, P., Multhaup, G., & Bayer, T. A.
- Affiliations
- Saarland University (DE)
- Universitätsklinikum des Saarlandes (DE)
- Freie Universität Berlin (DE)
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2005-09-09
- Volume
- 8
- Issue
- 1
- Pages
- 23-27
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W130613403
- Cited by
- 83
- References
- 20
- Citations by year
- 2026: 2 · 2025: 1 · 2023: 2 · 2022: 4 · 2021: 3 · 2020: 1 · 2019: 3 · 2018: 4 · 2017: 4 · 2016: 1 · 2015: 2 · 2014: 5 · 2013: 1 · 2012: 7
- FWCI
- 7.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Funders
- International Copper Association
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- Alzheimer's disease, copper
- MeSH terms
- Aged, Alzheimer Disease, Ceruloplasmin, Cognition Disorders, Copper, Female, Humans, Male, Neuropsychological Tests, Psychometrics, Statistics as Topic, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.